Elacestrant, sold under the brand name Orserdu, is a selective estrogen receptor degrader (SERD) used in the treatment of breast cancer. It is taken by mouth.
{{Infobox drug | image = Elacestrant.svg | image_class = skin-invert-image | width = 225px
| pronounce = | tradename = Orserdu | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = Elacestrant | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATCvet = | ATC_prefix = L02 | ATC_suffix = BA04 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).